Revolution Medicines Inc. (RVMD)
40.21
0.38 (0.95%)
At close: Jan 15, 2025, 10:32 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Revenue | 11.58M | 35.38M | 29.39M | 42.98M | 50.04M | 20.16M | n/a |
| Cost of Revenue | n/a | 9.66M | 7.33M | 132.25M | 91.75M | 1.76M | 1.19M |
| Gross Profit | 11.58M | 25.72M | 22.06M | -89.27M | -41.71M | 18.40M | -1.19M |
| Operating Income | -487.19M | -258.28M | -188.01M | -110.70M | -54.12M | -40.33M | -31.13M |
| Interest Income | 47.48M | 9.15M | 929.00K | 2.24M | 2.19M | 777.00K | 105.00K |
| Pretax Income | -439.89M | -249.13M | -187.09M | -108.53M | -52.04M | -41.79M | -31.13M |
| Net Income | -436.37M | -248.71M | -179.77M | -108.16M | -47.66M | -41.79M | -31.13M |
| Selling & General & Admin | 75.62M | 40.59M | 30.45M | 21.43M | 12.41M | 9.41M | 4.54M |
| Research & Development | 423.14M | 253.07M | 186.95M | 132.25M | 91.75M | 51.08M | 26.59M |
| Other Expenses | n/a | n/a | n/a | n/a | n/a | -2.12M | n/a |
| Operating Expenses | 498.76M | 293.66M | 217.40M | 153.68M | 104.16M | 60.49M | 31.13M |
| Interest Expense | 303.00K | n/a | 12.00K | 71.00K | 106.00K | 116.00K | 103.00K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 498.76M | 293.66M | 217.40M | 153.68M | 104.16M | 60.49M | 31.13M |
| Income Tax | -3.52M | -420.00K | -7.32M | -371.00K | -4.37M | -1.34M | 105.00K |
| Shares Outstanding (Basic) | 113.15M | 80.63M | 72.81M | 66.60M | 59.00M | 36.47M | 36.47M |
| Shares Outstanding (Diluted) | 113.15M | 80.63M | 72.81M | 66.60M | 59.00M | 36.47M | 36.47M |
| EPS (Basic) | -3.86 | -3.08 | -2.47 | -1.62 | -0.81 | -1.15 | -0.85 |
| EPS (Diluted) | -3.86 | -3.08 | -2.47 | -1.62 | -0.81 | -1.15 | -0.85 |
| EBITDA | -430.58M | -239.47M | -179.75M | -101.91M | -48.59M | -39.91M | -29.84M |
| Depreciation & Amortization | 9.31M | 9.66M | 7.33M | 6.54M | 3.34M | 1.76M | 1.19M |